Skip to content

Effects of Standing on Non-Ambulatory Children With Neuromuscular Conditions

Effects of Standing on Non-Ambulatory Children With Neuromuscular Conditions

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02428673
Enrollment
6
Registered
2015-04-29
Start date
2015-12-09
Completion date
2018-03-23
Last updated
2021-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy, Muscular Dystrophy, Osteopenia, Rett Syndrome, Spina Bifida, Spinal Muscular Atrophy

Keywords

Osteopenia, spinal muscular atrophy, cerebral palsy, muscular dystrophy, spina bifida, Rett Syndrome

Brief summary

Children with neuromuscular disabilities and limited ambulation are at significant risk for decreased bone mineral density (BMD) and increased incidence of fracture. This is caused, in part, by low levels of load experienced by the skeleton due to a child's functional limitations. Low BMD has been shown to be predictive of fracture, and in fact, fractures usually occur without significant trauma in children with neuromuscular conditions. The discomfort and distress from fractures in this population are considerable, and the associated costs to the family and healthcare system are substantial. Numerous interventions have been devoted to improving BMD in these children. Stationary assisted standing devices are widely used and represent the standard-of-care. However, evidence supporting this approach is limited due to inadequate study designs with insufficient numbers of patients. This study will use load-sensing platforms in patients with neuromuscular conditions. Successful completion of this pilot study will assist in the development of a future multicenter clinical trial to definitively determine relationships, if any, between passive standing and measures of BMD, fracture incidence, pulmonary function, and health-related quality-of-life measures in children with a variety of neuromuscular disabilities (e.g., spinal muscular atrophy, cerebral palsy, muscular dystrophy, spina bifida, Rett syndrome). Hypothesis: Assisted standing treatment program will gradually increase their duration of standing by up to 75% after the baseline phase.

Detailed description

Children with neuromuscular disabilities and limited ambulation are at significant risk for decreased bone mineral density (BMD) and increased incidence of fracture. This is caused, in part, by low levels of load experienced by the skeleton due to a child's functional limitations. Low BMD has been shown to be predictive of fracture, and in fact, fractures usually occur without significant trauma in children with neuromuscular conditions such as cerebral palsy, spinal muscular atrophy, or other muscular dystrophies. The discomfort and distress from fractures in this population are considerable, and the associated costs to the family and healthcare system are substantial. Numerous interventions have been devoted to improving BMD in these children. Stationary assisted standing devices are widely used and represent the standard-of-care. However, evidence supporting this approach is limited due to inadequate study designs with insufficient numbers of patients. Various modifications are added to assisted-standing devices to allow children with neuromuscular impairments to achieve standing postures. These customizations lead to load-sharing with the standing device, and consequently, a decrease in the amount of load passing through the lower extremities. Previous investigators developed custom-made load-measuring sensors to quantify the amount of load borne by the lower extremities while in passive standers, and found that the actual load varied from 23-102% of the child's body weight. These load-measuring sensors were specifically developed for restricted laboratory testing, rather than recording the load magnitude and duration of standing in any brand of standing device during daily use at home, school or therapy. We previously developed load-sensing platforms that accurately measure loads experienced by the lower extremities of children with cerebral palsy in passive standers. These platforms can be incorporated into any stander design, are able to be used on a routine basis at a child's home, school or therapy, and are able to record the duration of weight-bearing to monitor compliance. This study will use these load-sensing platforms in patients with neuromuscular conditions. Successful completion of this pilot study will assist in the development of a future multicenter clinical trial to definitively determine relationships, if any, between passive standing and measures of BMD, fracture incidence, pulmonary function, and health-related quality-of-life measures in children with a variety of neuromuscular disabilities (e.g., spinal muscular atrophy, cerebral palsy, muscular dystrophy, spina bifida, Rett syndrome).

Interventions

Sponsors

Gillette Children's Specialty Healthcare
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
3 Years to 14 Years
Healthy volunteers
No

Inclusion criteria

1. Must have a neuromuscular condition 2. Must be between 3-14 years old 3. Gross Motor Function Classification System (GMFCS) Level IV or V 4. Must be on a standing treatment program 5. Parent must be able to provide consent

Exclusion criteria

1\. Currently taking bisphosphonates

Design outcomes

Primary

MeasureTime frameDescription
Bone Mineral Density (BMD) (measured by DXA)10 monthsChange from baseline in BMD, as , at 10 months.
Bone Architecture (measured by pQCT)10 monthsChange from baseline in bone architecture, as measured by pQCT, at 10 months.

Secondary

MeasureTime frameDescription
Pediatric Quality of Life Inventory (PedsQL)10 monthsChange from baseline in PedsQL scores at 10 months.
Neuromuscular Module of the PedsQL10 monthsChange from baseline in PedsQL neuromuscular module scores at 10 months.
Change in pulmonary function test10 monthsChange from baseline in pulmonary function at 10 months.
Change in Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD)10 MonthsChange from baseline in CPCHILD score at 10 months.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026